The conversion of 2-beta-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties.

Source:http://linkedlifedata.com/resource/pubmed/id/6126195

Biochem. Pharmacol. 1982 Jun 1 31 11 2133-6

Download in:

View as

General Info

PMID
6126195